WO2012148200A3 - 허혈성 혈관 질환 치료시술 보조용 조성물 - Google Patents

허혈성 혈관 질환 치료시술 보조용 조성물 Download PDF

Info

Publication number
WO2012148200A3
WO2012148200A3 PCT/KR2012/003260 KR2012003260W WO2012148200A3 WO 2012148200 A3 WO2012148200 A3 WO 2012148200A3 KR 2012003260 W KR2012003260 W KR 2012003260W WO 2012148200 A3 WO2012148200 A3 WO 2012148200A3
Authority
WO
WIPO (PCT)
Prior art keywords
vascular diseases
composition
surgical procedures
ischemic vascular
treating ischemic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2012/003260
Other languages
English (en)
French (fr)
Other versions
WO2012148200A2 (ko
WO2012148200A9 (ko
Inventor
홍지만
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajou University Industry Academic Cooperation Foundation
Original Assignee
Ajou University Industry Academic Cooperation Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajou University Industry Academic Cooperation Foundation filed Critical Ajou University Industry Academic Cooperation Foundation
Priority to US14/113,762 priority Critical patent/US9956265B2/en
Priority claimed from KR1020120043799A external-priority patent/KR101609690B1/ko
Publication of WO2012148200A2 publication Critical patent/WO2012148200A2/ko
Publication of WO2012148200A3 publication Critical patent/WO2012148200A3/ko
Publication of WO2012148200A9 publication Critical patent/WO2012148200A9/ko
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

본 발명은 에리스로포이에틴(Erythropoietin, EPO)을 유효성분으로 포함하는 허혈성 혈관 질환 치료시술 보조용 조성물 및 상기 조성물을 이용하여 허혈성 혈관 질환을 치료하는 방법 등에 관한 것이다. 본 발명의 치료시술 보조용 조성물은 모야모야 질환을 비롯한 다양한 허혈성 혈관 질환이 발병된 성인 환자에게 다발천공 수술을 포함하는 다양한 치료시술 시 성공율을 향상시킬 수 있으며, 다양한 허혈성 혈관 질환의 치료에 널리 활용될 수 있을 것으로 기대된다.
PCT/KR2012/003260 2011-04-26 2012-04-26 허혈성 혈관 질환 치료시술 보조용 조성물 Ceased WO2012148200A2 (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US14/113,762 US9956265B2 (en) 2011-04-26 2012-04-26 Composition for aiding surgical procedures for treating ischemic vascular diseases

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
KR10-2011-0039219 2011-04-26
KR20110039219 2011-04-26
KR10-2012-0043799 2012-04-26
KR1020120043799A KR101609690B1 (ko) 2011-04-26 2012-04-26 허혈성 혈관 질환 치료시술 보조용 조성물

Publications (3)

Publication Number Publication Date
WO2012148200A2 WO2012148200A2 (ko) 2012-11-01
WO2012148200A3 true WO2012148200A3 (ko) 2013-01-17
WO2012148200A9 WO2012148200A9 (ko) 2013-03-14

Family

ID=47072926

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2012/003260 Ceased WO2012148200A2 (ko) 2011-04-26 2012-04-26 허혈성 혈관 질환 치료시술 보조용 조성물

Country Status (2)

Country Link
US (1) US9956265B2 (ko)
WO (1) WO2012148200A2 (ko)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20160140147A (ko) 2015-05-29 2016-12-07 주식회사 젬백스앤카엘 심장 허혈후 재관류 손상에 의한 심장 질환 치료 및 예방용 조성물
US11446084B2 (en) 2019-07-12 2022-09-20 Neuralink Corp. Laser drilling of pia mater
EP3964225A1 (en) * 2020-09-04 2022-03-09 Dompe' Farmaceutici S.P.A. Peptides endowed with angiogenic activity
CA3192758A1 (en) * 2020-09-04 2022-03-10 Dompe' Farmaceutici Spa Peptides endowed with angiogenic activity
CN118490406B (zh) * 2024-07-18 2024-10-11 四川大学华西医院 一种新型急性缺血性脑小血管病动物模型构建方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070298031A1 (en) * 1999-04-13 2007-12-27 Kenneth S. Warren Laboratories, Inc. Methods for preventing or treating neuromuscular or muscular conditions by peripherally administered erythropoietin
US20080031850A1 (en) * 2003-12-30 2008-02-07 Augustinus Bader Tissue Regeneration Method
KR20100077033A (ko) * 2002-07-26 2010-07-06 이피오플러스 게엠베하 운트 코. 카게 에리스로포이에틴의 용도
JP2010265301A (ja) * 1998-03-09 2010-11-25 Caritas St Elizabeth's Medical Center Of Boston Inc 血管新生を調整するための組成物及び方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19857609A1 (de) 1998-12-14 2000-06-15 Hannelore Ehrenreich Verwendung von Erythropoietin zur Behandlung von cerebralen Ischämien des Menschen
US6379363B1 (en) * 1999-09-24 2002-04-30 Walter Lorenz Surgical, Inc. Method and apparatus for reattachment of a cranial flap using a cranial clamp
US7767643B2 (en) * 2000-12-29 2010-08-03 The Kenneth S. Warren Institute, Inc. Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs
US6531121B2 (en) * 2000-12-29 2003-03-11 The Kenneth S. Warren Institute, Inc. Protection and enhancement of erythropoietin-responsive cells, tissues and organs
BRPI0410470A (pt) * 2003-05-19 2006-06-20 Kenneth S Warren Inst Inc uso de uma eritropoietina ou de uma citocina protetora de tecido e método para proteger ou manter a viabilidade de uma célula, tecido ou órgão de mamìfero respondente

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010265301A (ja) * 1998-03-09 2010-11-25 Caritas St Elizabeth's Medical Center Of Boston Inc 血管新生を調整するための組成物及び方法
US20070298031A1 (en) * 1999-04-13 2007-12-27 Kenneth S. Warren Laboratories, Inc. Methods for preventing or treating neuromuscular or muscular conditions by peripherally administered erythropoietin
KR20100077033A (ko) * 2002-07-26 2010-07-06 이피오플러스 게엠베하 운트 코. 카게 에리스로포이에틴의 용도
US20080031850A1 (en) * 2003-12-30 2008-02-07 Augustinus Bader Tissue Regeneration Method

Also Published As

Publication number Publication date
WO2012148200A2 (ko) 2012-11-01
US9956265B2 (en) 2018-05-01
WO2012148200A9 (ko) 2013-03-14
US20140045748A1 (en) 2014-02-13

Similar Documents

Publication Publication Date Title
WO2011127333A3 (en) Compounds for treating disease, for administering, and for pharmaceutical compositions
WO2012142093A3 (en) 2'-cyano substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
MX2018000421A (es) Composiciones de retinoides topicos.
EP4279128A3 (en) Novel antibody binding to tfpi and composition comprising the same
BR112015006341A2 (pt) compostos, composição farmacêutica, método para tratar condição fibrótica, quantidade terapeuticamente efetiva de composto, de sal farmaceuticamente aceitável deste ou de composição farmacêutica e usos das mesmas e de compostos e/ou composição farmacêutica
WO2012145133A3 (en) Occlusion-crossing devices, imaging, and atherectomy devices
MX363243B (es) Composiciones para tratar cáncer y usos de dichas composiciones.
WO2010093727A8 (en) Quinazolinones as prolyl hydroxylase inhibitors
HK1198869A1 (en) Combination treatments for hepatitis c
WO2010135056A3 (en) Phimosis treatment device and method
WO2010025321A3 (en) Method for treating multiple sclerosis patients with anti-il2r antibodies
WO2011041478A8 (en) Hematopoietic stem cells for use in the treatment of a kidney injury
WO2011156811A3 (en) Compounds for treatment of bovine mastitis
WO2012148200A3 (ko) 허혈성 혈관 질환 치료시술 보조용 조성물
WO2011097946A8 (zh) 含有并环稠合双环的噁唑烷酮化合物及其制备和应用
WO2013109342A8 (en) Method of treating diabetes using non-glycosylated apolipoprotein a-iv
AU2013330679A8 (en) Combination drug comprising gemigliptin and metformin, and method for the preparation thereof
EP4494705A3 (en) Non-peptide oxytocin receptor agonists
WO2009012784A3 (en) Methods for preparing cytotoxic complexes of emulsifier and fatty acid
WO2017011356A3 (en) Mcj inhibitors for use in treating drug-induced diseases and conditions
WO2012099899A3 (en) Topical dermatological compositions for the treatment of acne
WO2010101301A9 (en) Prophylaxis and treatment of macular degeneration and retinopathy using a prdx protein
WO2012103282A3 (en) Methods and compositions for treating alzheimer's disease
BR112013026644A2 (pt) método para a modulação da atividade de citocina
HK1209041A1 (en) A method of weight reduction

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12776674

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 14113762

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12776674

Country of ref document: EP

Kind code of ref document: A2